Previous Research


Study Background

The COVID-19 pandemic is a crisis affecting many globally requiring 5% of those infected admission into an intensive care unit. 

This is a Coronavirus clinical trial researching an existing Tuberculosis vaccine that may help with the prevention of severe symptoms associated with COVID-19 infection in higher-risk population groups. 


Eligibility Criteria

The participant must be in ONE of the following groups:

  • A Healthcare Worker
  • 65 Years and Older
  • 18 Years and Older with ONE of the following conditions:
    • Diabetes (Type I or II)
    • Asthma
    • High Blood Pressure
    • COPD
    • Emphysema
    • Previously have had a Heart Attack

The participant must also be negative for COVID-19



Study Details

The study would require participants to visit the clinic for up to an hour for only one visit. The participant would need to have a negative result of COVID-19 in the last 14 days to be vaccinated with either the study vaccine or a placebo. The participant would then download an app on their phone to fill out questionnaires periodically over the next 6 months. If a participant were to obtain symptoms related to COVID-19 they will need to be tested for the virus.